EA201070483A1 - Новые офтальмологические композиции - Google Patents

Новые офтальмологические композиции

Info

Publication number
EA201070483A1
EA201070483A1 EA201070483A EA201070483A EA201070483A1 EA 201070483 A1 EA201070483 A1 EA 201070483A1 EA 201070483 A EA201070483 A EA 201070483A EA 201070483 A EA201070483 A EA 201070483A EA 201070483 A1 EA201070483 A1 EA 201070483A1
Authority
EA
Eurasian Patent Office
Prior art keywords
ophthalmological compositions
new
new ophthalmological
compositions
salt
Prior art date
Application number
EA201070483A
Other languages
English (en)
Inventor
Аджай Джайсингх Кхопаде
Ариндам Халдер
Субхас Баларам Бховмик
Original Assignee
Сан Фарма Адвансед Ресьёрч Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сан Фарма Адвансед Ресьёрч Компани Лимитед filed Critical Сан Фарма Адвансед Ресьёрч Компани Лимитед
Publication of EA201070483A1 publication Critical patent/EA201070483A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Данное изобретение касается фармацевтической композиции, приемлемой для офтальмологического применения, включающей одно или более производных простагландина или его соли, стабилизирующее количество полиэтиленгликольгидроксистеарата и фармацевтически приемлемый носитель.
EA201070483A 2007-10-16 2008-10-15 Новые офтальмологические композиции EA201070483A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2061MU2007 2007-10-16
PCT/IN2008/000671 WO2009084021A2 (en) 2007-10-16 2008-10-15 Novel ophthalmic compositions

Publications (1)

Publication Number Publication Date
EA201070483A1 true EA201070483A1 (ru) 2010-10-29

Family

ID=40824837

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070483A EA201070483A1 (ru) 2007-10-16 2008-10-15 Новые офтальмологические композиции

Country Status (18)

Country Link
US (2) US9629852B2 (ru)
EP (1) EP2197449A4 (ru)
JP (1) JP5646331B2 (ru)
KR (1) KR101510185B1 (ru)
CN (1) CN101835473B (ru)
AU (1) AU2008344909B2 (ru)
BR (1) BRPI0818459A2 (ru)
CA (1) CA2702478C (ru)
CO (1) CO6270384A2 (ru)
EA (1) EA201070483A1 (ru)
EC (1) ECSP10010167A (ru)
IL (1) IL205095A0 (ru)
MX (1) MX2010004211A (ru)
NZ (1) NZ584555A (ru)
SG (1) SG185273A1 (ru)
UA (1) UA100393C2 (ru)
WO (1) WO2009084021A2 (ru)
ZA (1) ZA201002615B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010220061A1 (en) * 2009-02-20 2010-09-10 Micro Labs Limited Storage stable prostaglandin product
FR2961694B1 (fr) * 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
US9907826B2 (en) * 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
CN105012231A (zh) * 2014-04-30 2015-11-04 四川科伦药物研究院有限公司 一种包含PGF2α衍生物的稳定性良好的眼用制剂及其制备方法
US20190380958A1 (en) * 2016-12-28 2019-12-19 Chugai Seiyaku Kabushiki Kaisha Self-emulsifying drug formulation for improving membrane permeability of compound
CN110996954A (zh) * 2017-06-08 2020-04-10 眼科治疗有限责任公司 低剂量的溴莫尼定组合及其用途
KR20210032435A (ko) * 2018-07-12 2021-03-24 니콕스 에스아 산화질소 방출 프로스타미드를 함유하는 안과용 조성물
CN114245737A (zh) 2019-06-11 2022-03-25 司斐股份有限公司 微乳剂组合物
US11786538B2 (en) 2019-12-11 2023-10-17 Somerset Therapeutics, Llc Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties
JP2023544918A (ja) * 2020-10-13 2023-10-25 レンズ・セラピューティクス・インコーポレイテッド 保存安定性眼科用薬物のための組成物及び方法
JP2022120120A (ja) * 2022-06-13 2022-08-17 東亜薬品株式会社 眼科用水性組成物及びプロスタグランジンＦ２α誘導体の含量の低下を抑制する方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
EP1011728B1 (en) * 1998-07-14 2004-12-29 Alcon Manufacturing, Ltd. Polypropylene containers for prostaglandin products
KR100350179B1 (ko) * 1998-09-23 2002-08-27 구주제약주식회사 Ｓｅｄｄｓ로 제제화한 발기부전치료용 주입액제
JP3876355B2 (ja) * 2000-09-13 2007-01-31 参天製薬株式会社 点眼液
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
JP4092507B2 (ja) * 2003-07-31 2008-05-28 参天製薬株式会社 プロスタグランジン含有製品
US20050049311A1 (en) * 2003-09-03 2005-03-03 Pharmacia & Upjohn Company Medicinal products comprising prostaglandin compositions and methods of packaging such compositions
EP1655021B1 (en) * 2004-11-09 2008-10-29 Novagali Pharma SA Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
CA2578176C (en) * 2004-11-09 2013-09-24 Novagali Pharma Sa Ophthalmic emulsions containing an immunosuppressive agent
KR101382922B1 (ko) 2006-03-13 2014-04-08 가부시키가이샤 아루떼꾸 우에노 수성 조성물
WO2008074885A2 (en) * 2006-12-21 2008-06-26 Novagali Pharma Sa Process for manufacturing ophthalmic oil-in-water emulsions
US20080234376A1 (en) * 2007-03-21 2008-09-25 Taiwan Liposome Company (A Taiwan Corporation) Emulsion composition comprising prostaglandin e1
FR2918891B1 (fr) * 2007-07-20 2009-09-25 Thea Sa Lab Solution ophtalmique a base de prostaglandines sans conservateur

Also Published As

Publication number Publication date
JP5646331B2 (ja) 2014-12-24
MX2010004211A (es) 2010-06-30
CO6270384A2 (es) 2011-04-20
SG185273A1 (en) 2012-11-29
US20150290216A1 (en) 2015-10-15
JP2011508724A (ja) 2011-03-17
ECSP10010167A (es) 2010-06-29
CN101835473B (zh) 2012-12-05
US9539262B2 (en) 2017-01-10
UA100393C2 (ru) 2012-12-25
ZA201002615B (en) 2010-12-29
NZ584555A (en) 2012-03-30
CN101835473A (zh) 2010-09-15
KR20100087107A (ko) 2010-08-03
WO2009084021A2 (en) 2009-07-09
EP2197449A4 (en) 2013-10-09
US9629852B2 (en) 2017-04-25
CA2702478A1 (en) 2009-07-09
US20100137432A1 (en) 2010-06-03
EP2197449A2 (en) 2010-06-23
CA2702478C (en) 2014-12-09
IL205095A0 (en) 2010-11-30
KR101510185B1 (ko) 2015-04-10
AU2008344909A1 (en) 2009-07-09
WO2009084021A3 (en) 2009-12-03
AU2008344909B2 (en) 2013-06-06
BRPI0818459A2 (pt) 2015-04-14

Similar Documents

Publication Publication Date Title
EA201070483A1 (ru) Новые офтальмологические композиции
TR201802944T4 (tr) İlaç olarak azai̇ndazol veya di̇azai̇ndazol türünün türevleri̇
EA201390908A1 (ru) Производные бицикло[3.2.1]октиламида и их применение
ATE517882T1 (de) Chinolinderivate
EA201101672A1 (ru) Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина
EA201101671A1 (ru) Замещенные производные аминопропионовой кислоты в качестве ингибиторов неприлизина
EA200970156A1 (ru) Пиридизиноновые производные
EA201290191A1 (ru) N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ
GEP201606555B (en) Compounds and compositions for modulating egfr activity
EA200901319A1 (ru) Композиции для назального введения
ATE430744T1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
EA201692542A1 (ru) Индановые и индолиновые производные и их применение в качестве активаторов растворимой гуанилатциклазы
EA201490471A1 (ru) Пиридазиноновые соединения и их применение в качестве ингибиторов daao
EA200970913A1 (ru) 2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов
EA201291217A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ
BRPI0507198A (pt) derivados de bisariluréia
EA201071329A1 (ru) Диамидные производные адамантана и их применение
EA201990388A1 (ru) Пиперидиновые модуляторы рецепторов cxcr7
TW200626158A (en) Naphthaline derivatives
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
EA201891267A1 (ru) Фармацевтическая композиция, содержащая действенный ингибитор urat1
ATE536172T1 (de) Ezetimibzusammensetzungen
EA201992679A1 (ru) N-замещенные индольные производные
EA201001747A1 (ru) Бензоксазиноновые производные, действующие в качестве агониста бета-2-адренорецептора, для лечения респираторных расстройств
EA201101621A1 (ru) Производные бензоксазолона в качестве ингибиторов альдостеронсинтазы